Senior Failure Analysis Technician at PROCEPT BioRobotics

San Jose, California, United States

PROCEPT BioRobotics Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Medical Devices, Surgical Robotics, HealthcareIndustries

Requirements

  • High School Equivalent with 2-year experience, or 1-year technical degree/diploma with 1-year experience in a laboratory, testing, or failure analysis environment
  • Strong organizational skills with ability to manage multiple tasks simultaneously
  • Knowledge of Good Documentation Practices (GDP) and experience writing technical reports that withstand regulatory and audit scrutiny

Responsibilities

  • Manage the failure analysis laboratory, including handling devices exposed to bloodborne pathogens
  • Maintain a clean, organized, and compliant lab environment in accordance with safety, biosafety, and 5S lean principles
  • Track and manage a high volume of devices through the failure analysis workflow, ensuring accurate labeling, chain-of-custody, and status tracking
  • Perform detailed physical and functional testing on devices using advanced tools (e.g., oscilloscopes, data acquisition systems) as well as capital equipment test setups
  • Conduct complaint and failure investigations, working closely with design, quality, and reliability engineers to identify root causes
  • Document test protocols, results, and findings with precision, following Good Documentation Practices (GDP) and ensuring records are audit-ready
  • Write clear, structured investigation reports that meet regulatory, quality system, and audit requirements
  • Collaborate with engineers to analyze test outcomes and recommend potential next steps in root cause analysis
  • Support continuous improvement by identifying gaps in lab processes, documentation, and equipment management
  • Ensure all test equipment is properly maintained, calibrated, and compliant with internal and external standards

Skills

Failure Analysis
Root Cause Analysis
Complaint Investigations
Device Testing
Lab Management
Biosafety
5S Lean
Regulatory Compliance
Surgical Robotics

PROCEPT BioRobotics

Develops robotic solutions for BPH treatment

About PROCEPT BioRobotics

PROCEPT BioRobotics develops robotic solutions specifically for treating benign prostatic hyperplasia (BPH), a condition that affects many older men by causing prostate enlargement and urinary issues. Their main product, the AquaBeam Robotic System, utilizes Aquablation therapy, which combines real-time imaging, robotics, and waterjet technology to precisely remove prostate tissue in a minimally invasive manner. This system is designed for urologists and healthcare facilities, focusing on enhancing patient outcomes and making surgical procedures more efficient. Unlike competitors, PROCEPT BioRobotics emphasizes predictable results and reduced complications, which has led to their technology being recognized in clinical guidelines. The company's goal is to improve the quality of life for patients suffering from BPH through advanced surgical solutions.

Redwood City, CaliforniaHeadquarters
2009Year Founded
$319.1MTotal Funding
IPOCompany Stage
Robotics & Automation, HealthcareIndustries
501-1,000Employees

Benefits

Health Insurance
401(k) Company Match
401(k) Retirement Plan
Paid Vacation
Paid Parental Leave
Paid Holidays
Wellness Program
Gym Membership

Risks

Competition from Intuitive Surgical and Medtronic may impact market share.
$175 million public stock offering could lead to shareholder dilution.
Reliance on AquaBeam System makes company vulnerable to technological failures.

Differentiation

AquaBeam Robotic System offers image-guided, minimally invasive urologic surgery.
Aquablation therapy provides effective outcomes regardless of prostate size or surgeon experience.
PROCEPT has over 100 peer-reviewed publications supporting Aquablation therapy's benefits.

Upsides

Increasing adoption of robotic-assisted surgeries boosts demand for AquaBeam System.
Global urology devices market projected to grow at 6.9% CAGR until 2030.
FDA's supportive regulatory environment favors innovative medical technologies like PROCEPT's.

Land your dream remote job 3x faster with AI